Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction 1 - STOP-AMI 1

Description:

The STOP-AMI 1 trial was a randomized trial designed to compare coronary stenting plus glycoprotein IIb/IIIa inhibition using abciximab to fibrinolytic therapy with alteplase in patients with ST-elevation myocardial infarction (STEMI).